Gall Matthew 4
4 · iTeos Therapeutics, Inc. · Filed Oct 12, 2021
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-10-11−14,429→ 42,388 totalExercise: $6.16Exp: 2030-06-18→ Common Stock (14,429 underlying) - Exercise/Conversion
Common Stock
2021-10-11$6.16/sh+14,429$88,883→ 19,429 total
Footnotes (2)
- [F1]This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
- [F2]One-fourth of the shares subject to the stock option vested on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.